Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. (Record no. 27457910)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02190 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517170311.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1365-2125 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1111/bcp.13397 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Pressiat, Claire |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180131 |
| 245 00 - TITLE STATEMENT | |
| Title | Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | British journal of clinical pharmacology |
| Date of publication, distribution, etc. | 12 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2729-2740 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | AIDS-Related Opportunistic Infections |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Bacterial Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Burkina Faso |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Child, Preschool |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Coinfection |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Computer Simulation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cote d'Ivoire |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Infections |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | HIV Protease Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infant |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lopinavir |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metabolic Clearance Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Models, Biological |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nonlinear Dynamics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pneumonia, Pneumocystis |
| General subdivision | immunology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Practice Guidelines as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trimethoprim, Sulfamethoxazole Drug Combination |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | World Health Organization |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mea-Assande, Veronique |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yonaba, Caroline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Treluyer, Jean-Marc |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dahourou, Désiré-Lucien |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Amorissani-Folquet, Madeleine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blanche, Stéphane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eboua, François |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ye, Diarra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lui, Gabrielle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Malateste, Karen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zheng, Yi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leroy, Valeriane |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hirt, Déborah |
| 773 0# - HOST ITEM ENTRY | |
| Title | British journal of clinical pharmacology |
| Related parts | vol. 83 |
| -- | no. 12 |
| -- | p. 2729-2740 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1111/bcp.13397">https://doi.org/10.1111/bcp.13397</a> |
| Public note | Available from publisher's website |
No items available.